283 related articles for article (PubMed ID: 11769768)
21. Mortality rates and recurrent rates of tuberculosis in patients with smear-negative pulmonary tuberculosis and tuberculous pleural effusion who have completed treatment.
Banda H; Kang'ombe C; Harries AD; Nyangulu DS; Whitty CJ; Wirima JJ; Salaniponi FM; Maher D; Nunn P
Int J Tuberc Lung Dis; 2000 Oct; 4(10):968-74. PubMed ID: 11055765
[TBL] [Abstract][Full Text] [Related]
22. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy.
Mehta J; Keith R; Al Hasan M; Ryland B; Roy T
Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201
[TBL] [Abstract][Full Text] [Related]
23. Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia.
Sar B; Keo C; Leng C; Saman M; Min DC; Chan S; Monchy D; Sarthou JL
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):104-7. PubMed ID: 19323041
[TBL] [Abstract][Full Text] [Related]
24. Review of multidrug-resistant and extensively drug-resistant TB: global perspectives with a focus on sub-Saharan Africa.
Migliori GB; Dheda K; Centis R; Mwaba P; Bates M; O'Grady J; Hoelscher M; Zumla A
Trop Med Int Health; 2010 Sep; 15(9):1052-66. PubMed ID: 20545927
[TBL] [Abstract][Full Text] [Related]
25. Extensively drug-resistant tuberculosis in sub-Saharan Africa: an emerging public-health concern.
Jones KD; Hesketh T; Yudkin J
Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):219-24. PubMed ID: 18243260
[TBL] [Abstract][Full Text] [Related]
26. Extensively drug-resistant tuberculosis: new strains, new challenges.
Banerjee R; Schecter GF; Flood J; Porco TC
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
[TBL] [Abstract][Full Text] [Related]
27. Tuberculosis in those with HIV infection.
Thomas MG; Ellis-Pegler RB
N Z Med J; 1997 Sep; 110(1052):352-4. PubMed ID: 9364176
[TBL] [Abstract][Full Text] [Related]
28. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
Li J; Munsiff SS; Driver CR; Sackoff J
Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
[TBL] [Abstract][Full Text] [Related]
29. Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Mar; 51(10):214-5. PubMed ID: 11922192
[TBL] [Abstract][Full Text] [Related]
30. Short-course instead of long-course chemotherapy for smear-negative patients in sub-Saharan Africa.
van Gorkom J; van Cleeff M; Becx-Bleumink M; Veen J
Int J Tuberc Lung Dis; 2001 Jan; 5(1):4-11. PubMed ID: 11263514
[TBL] [Abstract][Full Text] [Related]
31. First-line antituberculosis drug resistance prevalence and its pattern among HIV-infected patients in the national referral tuberculosis centre, Iran.
Tabarsi P; Chitsaz E; Moradi A; Baghaei P; Farnia P; Marjani M; Irannejad P; Mansouri D; Masjedi M
Int J STD AIDS; 2009 Aug; 20(8):566-70. PubMed ID: 19625590
[TBL] [Abstract][Full Text] [Related]
32. The TB pandemic: an old problem seeking new solutions.
Meya DB; McAdam KP
J Intern Med; 2007 Apr; 261(4):309-29. PubMed ID: 17391107
[TBL] [Abstract][Full Text] [Related]
33. Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina.
Palmero DJ; Ambroggi M; Brea A; De Lucas M; Fulgenzi A; Martínez D; Mosca C; Musella R; Natiello M; Gonzalez C; Abbate E
Int J Tuberc Lung Dis; 2004 Jun; 8(6):778-84. PubMed ID: 15182150
[TBL] [Abstract][Full Text] [Related]
34. How human immunodeficiency virus voluntary testing can contribute to tuberculosis control.
Godfrey-Faussett P; Maher D; Mukadi YD; Nunn P; Perriëns J; Raviglione M
Bull World Health Organ; 2002; 80(12):939-45. PubMed ID: 12571721
[TBL] [Abstract][Full Text] [Related]
35. Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy.
Sungkanuparph S; Eampokalap B; Chottanapund S; Bed ST; Manosuthi W
J Med Assoc Thai; 2007 May; 90(5):884-8. PubMed ID: 17596041
[TBL] [Abstract][Full Text] [Related]
36. Recurrent tuberculosis: definitions and treatment regimens.
Harries AD; Hargreaves NJ; Kwanjana JH; Salaniponi FM
Int J Tuberc Lung Dis; 1999 Oct; 3(10):851-4. PubMed ID: 10524580
[TBL] [Abstract][Full Text] [Related]
37. [Exogenous re-infection in tuberculosis].
Tsuchiya T
Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009
[TBL] [Abstract][Full Text] [Related]
38. Factors predicting non-completion of tuberculosis treatment among HIV-infected patients in Barcelona (1987-1996).
Tangüis HG; Caylà JA; García de Olalla PG; Jansà JM; Brugal MT
Int J Tuberc Lung Dis; 2000 Jan; 4(1):55-60. PubMed ID: 10654645
[TBL] [Abstract][Full Text] [Related]
39. Can we get more HIV-positive tuberculosis patients on antiretroviral treatment in a rural district of Malawi?
Zachariah R; Teck R; Ascurra O; Gomani P; Manzi M; Humblet P; Nunn P; Salaniponi FM; Harries AD
Int J Tuberc Lung Dis; 2005 Mar; 9(3):238-47. PubMed ID: 15786885
[TBL] [Abstract][Full Text] [Related]
40. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
